Vol. 6 No. 1 (2020): Articles in Press
Case Report

Resolution of Chemotherapy-Induced Peripheral Neuropathy with Subanesthetic Ketamine: A Case Report

Khan M
Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA
Nguyen M
Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA
Kerulis M
The Family Institute at Northwestern University, Evanston, IL, USA
Bal N
Ketamine Centers of Chicago, Chicago, IL, USA
Prabhneet P
Aureus University School of Medicine, Oranjestad, Aruba
Irv W
Ketamine Centers of Chicago, Chicago, IL, USA
Published August 12, 2020
Keywords
  • Chemotherapy,
  • Neuropathy,
  • Ketamine

Abstract

Chemotherapeutic drugs have been shown to induce peripheral neuropathy which can become very painful, diminish functional ability, and decrease quality of life. Although Chemotherapy-Induced Peripheral Neuropathy (CIPN) may resolve completely in some individuals, others demonstrate partial or no resolution of symptoms. Presented is a case in which a female patient with a 2-year history of severe CIPN following the diagnosis and treatment of stage 3 triple negative BRCA 1 breast cancer was able to attain complete resolution of her symptoms after the use of subanesthetic ketamine.